Back to search results

A Post Marketing Surveillance on Piqray in Korea

Abroad (travel likely)Recruiting

Conditions

Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Novartis Investigative Site, Cheonan Si, Chungcheongnam-do, South Korea

  • Novartis Investigative Site, Daegu, Dalseo gu, South Korea

  • Novartis Investigative Site, Goyang-si, Gyeonggi-do, South Korea

  • Novartis Investigative Site, Suwon, Gyeonggi-do, South Korea

  • Novartis Investigative Site, Gyeonggi-do, Korea, South Korea

  • Novartis Investigative Site, Seoul, Korea, South Korea

  • Novartis Investigative Site, Seoul, Seoul, South Korea

  • Novartis Investigative Site, Seoul, Seoul, South Korea

  • Novartis Investigative Site, Seoul, Yangcheon gu, South Korea

  • Novartis Investigative Site, Busan, South Korea

  • Novartis Investigative Site, Busan, South Korea

  • Novartis Investigative Site, Daegu, South Korea

  • Novartis Investigative Site, Daejeon, South Korea

  • Novartis Investigative Site, Jeollanam, South Korea

  • Novartis Investigative Site, Kyunggi, South Korea

  • Novartis Investigative Site, Seoul, South Korea

  • Novartis Investigative Site, Seoul, South Korea

  • Novartis Investigative Site, Seoul, South Korea

  • Novartis Investigative Site, Seoul, South Korea

Study leads

  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals

View source on ClinicalTrials.gov(opens in a new tab)